Literature DB >> 25862776

Drug-induced glomerular disease: direct cellular injury.

Glen S Markowitz1, Andrew S Bomback2, Mark A Perazella3.   

Abstract

The potential of medications to cause kidney injury is well known. Although nephrotoxicity is most commonly associated with injury in the tubulointerstitial compartment as either acute tubular necrosis or acute interstitial nephritis, a growing body of literature has also highlighted the potential for drug-induced glomerular lesions. This review surveys the three primary patterns of drug-induced glomerular diseases stratified by the cell type at which the glomerular lesion is focused: visceral epithelial cell (or podoctye) injury, endothelial cell injury, and mesangial cell injury. A number of commonly prescribed medications, including IFNs, bisphosphonates, nonsteroidal anti-inflammatory drugs, antiplatelet agents, and antiangiogenesis drugs, that are both prescribed and available over the counter, have been implicated in these iatrogenic forms of glomerular disease. Recognition of these drug-induced etiologies of glomerular disease and rapid discontinuation of the offending agent are critical to maximizing the likelihood of renal function recovery.
Copyright © 2015 by the American Society of Nephrology.

Entities:  

Keywords:  GN; drug nephrotoxicity; glomerular disease

Mesh:

Year:  2015        PMID: 25862776      PMCID: PMC4491280          DOI: 10.2215/CJN.00860115

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  71 in total

1.  Virus interference. I. The interferon.

Authors:  A ISAACS; J LINDENMANN
Journal:  Proc R Soc Lond B Biol Sci       Date:  1957-09-12

Review 2.  Thrombotic thrombocytopenic purpura and other thrombotic microangiopathic hemolytic anemias: diagnosis and classification.

Authors:  Boris Shenkman; Yulia Einav
Journal:  Autoimmun Rev       Date:  2014-01-11       Impact factor: 9.754

3.  Tubuloreticular inclusions in placental chorionic villi of rhesus monkeys after maternal treatment with interferon.

Authors:  D Feldman; R M Hoar; W H Niemann; T Valentine; M Cukierski; A G Hendrickx
Journal:  Am J Obstet Gynecol       Date:  1986-08       Impact factor: 8.661

Review 4.  Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis.

Authors:  Xiaolei Zhu; Shenhong Wu; William L Dahut; Chirag R Parikh
Journal:  Am J Kidney Dis       Date:  2007-02       Impact factor: 8.860

5.  Tobacco smoke is a source of toxic reactive glycation products.

Authors:  C Cerami; H Founds; I Nicholl; T Mitsuhashi; D Giordano; S Vanpatten; A Lee; Y Al-Abed; H Vlassara; R Bucala; A Cerami
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

6.  APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.

Authors:  Jeffrey B Kopp; George W Nelson; Karmini Sampath; Randall C Johnson; Giulio Genovese; Ping An; David Friedman; William Briggs; Richard Dart; Stephen Korbet; Michele H Mokrzycki; Paul L Kimmel; Sophie Limou; Tejinder S Ahuja; Jeffrey S Berns; Justyna Fryc; Eric E Simon; Michael C Smith; Howard Trachtman; Donna M Michel; Jeffrey R Schelling; David Vlahov; Martin Pollak; Cheryl A Winkler
Journal:  J Am Soc Nephrol       Date:  2011-10-13       Impact factor: 10.121

Review 7.  Ticlopidine- and clopidogrel-associated thrombotic thrombocytopenic purpura (TTP): review of clinical, laboratory, epidemiological, and pharmacovigilance findings (1989-2008).

Authors:  Anaadriana Zakarija; Hau C Kwaan; Joel L Moake; Nicholas Bandarenko; Dilip K Pandey; June M McKoy; Paul R Yarnold; Dennis W Raisch; Jeffrey L Winters; Thomas J Raife; John F Cursio; Thanh Ha Luu; Elizabeth A Richey; Matthew J Fisher; Thomas L Ortel; Martin S Tallman; X Long Zheng; Masanori Matsumoto; Yoshihiro Fujimura; Charles L Bennett
Journal:  Kidney Int Suppl       Date:  2009-02       Impact factor: 10.545

8.  Idiopathic nodular glomerulosclerosis: a clinicopathologic study of 15 cases.

Authors:  Wei Li; Regina R Verani
Journal:  Hum Pathol       Date:  2008-08-12       Impact factor: 3.466

9.  Nephrotic syndrome associated with use of the nonsteroidal anti-inflammatory drugs. Case report and review of the literature.

Authors:  D A Feinfeld; L Olesnicky; C L Pirani; G B Appel
Journal:  Nephron       Date:  1984       Impact factor: 2.847

10.  Idiopathic lobular glomerulonephritis (nodular mesangial sclerosis): a distinct diagnostic entity.

Authors:  C E Alpers; C G Biava
Journal:  Clin Nephrol       Date:  1989-08       Impact factor: 0.975

View more
  19 in total

Review 1.  Nephrotoxicity of Cancer Immunotherapies: Past, Present and Future.

Authors:  Mark A Perazella; Anushree C Shirali
Journal:  J Am Soc Nephrol       Date:  2018-06-29       Impact factor: 10.121

2.  Idiopathic collapsing focal segmental glomerulosclerosis in an 81-year-old Japanese woman: a case report and review of the literature.

Authors:  Jun Yamazaki; Eriko Kanehisa; Wakaba Yamaguchi; Jiro Kumagai; Kiyotaka Nagahama; Hajime Fujisawa
Journal:  CEN Case Rep       Date:  2016-06-15

3.  Protective effect of cilastatin against diclofenac-induced nephrotoxicity through interaction with diclofenac acyl glucuronide via organic anion transporters.

Authors:  Xiaokui Huo; Qiang Meng; Changyuan Wang; Jingjing Wu; Chong Wang; Yanna Zhu; Xiaodong Ma; Huijun Sun; Kexin Liu
Journal:  Br J Pharmacol       Date:  2020-03-05       Impact factor: 8.739

Review 4.  Drug-Induced Kidney Injury in the Elderly.

Authors:  Sana Khan; Valentina Loi; Mitchell H Rosner
Journal:  Drugs Aging       Date:  2017-10       Impact factor: 3.923

Review 5.  Acute kidney injury in cancer patients.

Authors:  Shuiying Liu; Jinyuan Zhao; Feng Wang
Journal:  Clin Exp Nephrol       Date:  2021-09-09       Impact factor: 2.801

6.  Pretreatment of carprofen impaired initiation of inflammatory- and overlapping resolution response and promoted cardiorenal syndrome in heart failure.

Authors:  Veena Krishnan; David Booker; Gabrielle Cunningham; Jeevan Kumar Jadapalli; Vasundhara Kain; Amanda B Pullen; Ganesh V Halade
Journal:  Life Sci       Date:  2018-12-28       Impact factor: 5.037

Review 7.  [(Immuno‑)Pathology of drug side effects in the kidney].

Authors:  F Pfister; M Büttner-Herold; K Amann
Journal:  Pathologe       Date:  2018-11       Impact factor: 1.011

8.  Drug-induced kidney disease: a study of the Japan Renal Biopsy Registry from 2007 to 2015.

Authors:  Hitoshi Yokoyama; Ichie Narita; Hitoshi Sugiyama; Michio Nagata; Hiroshi Sato; Yoshihiko Ueda; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2015-11-21       Impact factor: 2.801

9.  Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab.

Authors:  Marco Allinovi; Calogero Lino Cirami; Leonardo Caroti; Giulia Antognoli; Silvia Farsetti; Maria Pia Amato; Enrico Eugenio Minetti
Journal:  Clin Kidney J       Date:  2017-02-16

10.  Progressive renal insufficiency related to ALK inhibitor, alectinib.

Authors:  Kojiro Nagai; Hiroyuki Ono; Motokazu Matsuura; Michael Hann; Sayo Ueda; Sakiya Yoshimoto; Masanori Tamaki; Taichi Murakami; Hideharu Abe; Hisashi Ishikura; Toshio Doi
Journal:  Oxf Med Case Reports       Date:  2018-04-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.